Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK — Four New York shops remain in the running to handle ad duties on FluMist, a new flu vaccine from Wyeth Laboratories and MedImmune that will be delivered as a nasal spray, sources said.
The shops are Foote, Cone & Belding, McCann-Erickson, Saatchi & Saatchi and Euro RSCG MVBMS Partners, said sources. Final presentations are scheduled for the week of Oct. 14, with a decision shortly thereafter.
Billings have not been determined but sources estimated that the client would spend $30-40 million to launch the brand.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in